2029 Related Topics 
Hospice News
JANUARY 19, 2023
billion by 2029, a rise from $76.44 The hospice market is expected to nearly double in the next decade, reaching $64.7 billion in 2030 from $34.5 billion in 2022, a report from ResearchandMarkets estimated. For behavioral health, projections run as high as $105.14 billion in 2021, according to Fortune Business Insights.
Freedom Home Care and Medical Staffing
DECEMBER 5, 2023
Bureau of Labor Statistics, the employment of home health and personal care aides is projected to grow by 34% from 2019 to 2029, much faster than the average for all occupations. According to the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Freedom Home Care and Medical Staffing
NOVEMBER 27, 2023
Bureau of Labor Statistics, the employment of home health and personal care aides is projected to grow by 34% from 2019 to 2029, much faster than the average for all occupations. According to the U.S.
Freedom Home Care and Medical Staffing
NOVEMBER 25, 2023
Bureau of Labor Statistics, the employment of home health and personal care aides is projected to grow by 34% from 2019 to 2029, much faster than the average for all occupations. According to the U.S.
Diversity Nursing
APRIL 13, 2021
The Bureau of Labor Statistics (BLS) reports , the o verall employment of Nurse Practitioners is projected to grow 45% from 2019 to 2029, much faster than the average for all occupations. According to the American Association of Nurse Practitioners ( AANP ), in 2019, there were more than 290,000 licensed NPs in the United States.
Diversity Nursing
JULY 7, 2021
Bureau of Labor Statistics (BLS), employment of Registered Nurses is projected to grow 7% from 2019 - 2029, faster than the average for all occupations. The Association of American Medical Colleges (AAMC) projects a shortage of between 54,100 - 139,000 Physicians by the year 2033. And, According to the U.S.
Healthcare Law Insights blog
NOVEMBER 8, 2022
The Secretary is required to negotiate prices for 10 single-source drugs, beginning in 2026 and increasing each subsequent year through 2029, when 20 single-source drugs will be chosen for pricing negotiation. Small Biotech” drugs are also excluded until 2029.
Expert insights. Personalized for you.
246 
Let's personalize your content